Hydrocortisone



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 19.6%
Acute Lymphocytic Leukaemia 12.4%
Addison's Disease 7.3%
Adrenal Insufficiency 6.9%
Drug Use For Unknown Indication 5.4%
Dermatitis Atopic 4.8%
Adrenogenital Syndrome 4.2%
B Precursor Type Acute Leukaemia 4.2%
Colitis Ulcerative 3.9%
Asthma 3.6%
Eczema 3.6%
Pain 3.6%
Hypopituitarism 3.3%
Non-hodgkin's Lymphoma 3.0%
Chemotherapy 2.4%
Immunosuppression 2.4%
Lymphoblastic Lymphoma 2.4%
Lymphocytic Leukaemia 2.4%
Adrenal Disorder 2.1%
Bone Marrow Transplant 2.1%
Drug Ineffective 12.9%
Epidural Lipomatosis 10.3%
Weight Increased 8.6%
Nocardiosis 7.8%
Drug Hypersensitivity 6.0%
Myelopathy 5.2%
Pallor 5.2%
Renal Failure Acute 5.2%
Hypersensitivity 4.3%
Loss Of Consciousness 4.3%
Diabetes Insipidus 3.4%
Product Substitution Issue 3.4%
Pyrexia 3.4%
Rash 3.4%
Weight Decreased 3.4%
Accidental Exposure 2.6%
Adrenal Insufficiency 2.6%
Adrenocortical Insufficiency Acute 2.6%
Cushing's Syndrome 2.6%
Hypertension 2.6%
Secondary
Acute Lymphocytic Leukaemia 33.4%
Product Used For Unknown Indication 13.3%
Chromosome Analysis Abnormal 10.0%
Drug Use For Unknown Indication 5.6%
Burkitt's Lymphoma 5.4%
B Precursor Type Acute Leukaemia 4.8%
Asthma 3.2%
Prophylaxis 3.0%
Hypertension 3.0%
Central Nervous System Lymphoma 2.1%
Bacteraemia 2.0%
Prostate Cancer Metastatic 1.9%
Acute Myeloid Leukaemia 1.8%
Rheumatoid Arthritis 1.7%
Precursor T-lymphoblastic Lymphoma/leukaemia 1.7%
Rhabdomyosarcoma 1.6%
Antifungal Prophylaxis 1.5%
Burkitt's Lymphoma Stage Iii 1.5%
Pain 1.4%
Crohn's Disease 1.3%
Toxic Epidermal Necrolysis 12.3%
Off Label Use 11.7%
Vomiting 8.9%
Weight Increased 6.0%
Loss Of Consciousness 5.7%
Thrombocytopenia 5.5%
Pyrexia 5.0%
Tachycardia Foetal 4.2%
Pulmonary Embolism 3.9%
Rhabdomyolysis 3.7%
Sepsis 3.7%
Spinal Fracture 3.7%
Drug Ineffective 3.4%
Multi-organ Failure 3.4%
Rash 3.4%
White Blood Cell Count Decreased 3.4%
Zygomycosis 3.4%
Pneumonitis 3.1%
Renal Failure Acute 2.9%
Tendonitis 2.9%
Concomitant
Product Used For Unknown Indication 30.2%
Drug Use For Unknown Indication 17.0%
Premedication 10.6%
Crohn's Disease 6.7%
Pain 4.5%
Prophylaxis 4.0%
Hypertension 3.5%
Hypopituitarism 3.0%
Hiv Infection 2.5%
Rheumatoid Arthritis 2.3%
Depression 1.9%
Growth Hormone Deficiency 1.8%
Colitis Ulcerative 1.7%
Nausea 1.6%
Diabetes Mellitus 1.5%
Osteoporosis 1.5%
Asthma 1.5%
Blood Corticotrophin Decreased 1.4%
Acute Lymphocytic Leukaemia 1.4%
Constipation 1.4%
Vomiting 17.6%
Weight Decreased 6.8%
Death 6.4%
Sepsis 5.6%
Pneumonia 5.5%
Pyrexia 4.9%
Rash 4.8%
Thrombocytopenia 4.8%
Tachycardia 4.6%
Infusion Related Reaction 3.9%
Weight Increased 3.8%
Renal Failure 3.7%
Septic Shock 3.7%
Urinary Tract Infection 3.6%
Respiratory Failure 3.6%
Urticaria 3.5%
White Blood Cell Count Decreased 3.5%
Nausea 3.4%
Diarrhoea 3.1%
Renal Failure Acute 3.1%
Interacting
Cerebrovascular Accident 14.5%
Hypertension 14.5%
Addison's Disease 8.1%
Asthma 8.1%
Abortion Induced 6.5%
Convulsion 6.5%
Adrenal Insufficiency 4.8%
Fibromyalgia 4.8%
Hypopituitarism 4.8%
Adrenalectomy 3.2%
Analgesic Therapy 3.2%
Antibiotic Therapy 3.2%
Drug Use For Unknown Indication 3.2%
Respiratory Failure 3.2%
Upper Gastrointestinal Haemorrhage 3.2%
Actinic Keratosis 1.6%
Cardiac Failure 1.6%
Gastrointestinal Haemorrhage 1.6%
Glucocorticoids Decreased 1.6%
High Density Lipoprotein Decreased 1.6%
Toxicity To Various Agents 17.4%
Drug Interaction 8.7%
Hepatitis Toxic 8.7%
Osteonecrosis Of Jaw 8.7%
Respiratory Failure 8.7%
Chills 4.3%
Fall 4.3%
Feeling Abnormal 4.3%
Fibromyalgia 4.3%
Loss Of Consciousness 4.3%
Mixed Liver Injury 4.3%
Osteonecrosis 4.3%
Skin Burning Sensation 4.3%
Vomiting 4.3%
Weight Decreased 4.3%
Weight Increased 4.3%